Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
ETS proteins are a family of transcription factors that play important roles in the development of cancer. The Ewing's sarcoma EWS/ETS fusion oncoproteins control a number of cancer-relevant phenotypes in that disease. We recently demonstrated that EWS/FLI, the most common EWS/ETS fusion in Ewing's sarcoma, regulates a portion of its target genes, including the critical target NR0B1, via GGAA-containing microsatellites in their promoters. Given the unusual nature of microsatellites as EWS/FLI response elements, we sought to elucidate the mechanism of EWS/FLI activity at these sites. We found that the ability to bind GGAA microsatellites is shared by multiple ETS family members from distinct phylogenetic subfamilies. Importantly, however, only EWS/ETS-containing fusions are capable of mediating transcriptional activation via these elements, highlighting a neomorphic function of the Ewing's sarcoma fusion proteins. Additional analysis revealed that the GGAA microsatellite binds EWS/FLI with an affinity that is 2 to 3 orders of magnitude lower than previously identified high-affinity consensus/redundant binding sites. The stoichiometry of this interaction is 2 protein molecules for each DNA molecule, suggesting that EWS/FLI binds these elements as a homodimer. The isolated FLI ETS domain bound microsatellite sequences in a nearly identical fashion to full-length EWS/FLI, thus indicating that residues required for homodimeric binding are localized to the ETS domain. These data suggest a new paradigm for an ETS family member binding to DNA at cancer-relevant genetic loci and highlight emergent properties of EWS/FLI that are required for the development of Ewing's sarcoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, four or more repeats are necessary for EWS-FLI1 transcriptional activation in reporter assays, and two EWS-FLI1 monomers bind to this four-motif array in biochemical assays (Figure 7) (133, 137, 187).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [187]
In the citing paper
“This implicates the ETS-domain component of the fusion protein in microsatellite binding (187).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · cited 4×
“As a consequence of the (11;22) translocation, the amino terminal transcriptional activation domain of FLI is replaced by the amino terminus of EWS.(6) Because the EWS portion of the fusion functions as a strong transcriptional activation domain when fused to heterologous DNA-binding domains, one model for EWS/FLI fun…”
InfluentialThe ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
Sorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Self-citationMay, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., & Denny, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5752 · Cited by 574 · cited 1×
“2A).(14) We found that Δ22 was inactive in luciferase reporter assays (Fig.”
Self-citationMay, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7393 · Cited by 497 · cited 5×
“EWS is an RNA-binding protein of uncertain normal function, while FLI is an ETS family member normally involved in hematopoietic development.18,19 Wild-type FLI contains a weak transcriptional activation domain in its amino terminus and an ETS-type DNA-binding domain and a second transcriptional activation domain in i…”
InfluentialSelf-citationA variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
Jeon, I. S., Davis, J. N., Braun, B. S., Sublett, J. E., Roussel, M. F., Denny, C. T., & Shapiro, D. N. (1995) · PubMed · Cited by 471
ETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469 · cited 1×
“The ETS family is defined by the presence of a highly conserved ETStype DNA-binding domain.(1) ETS domains generally bind DNA at 9- to 10-bp sequences that contain a “GGAA/T core” motif surrounded by bases that dictate the affinity of the interaction.”
Turc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J. P., Olschwang, S., Philip, I., Berger, M. P., et al. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90285-3 · Cited by 466 · cited 2×
“EWS/FLI, ETS, Ewing’s sarcoma, microsatellites 178 Genes & Cancer / vol 1 no 2 (2010) 85% of Ewing’s sarcoma tumors contain a recurrent chromosomal translocation, t(11;22)(q24;q12), that encodes EWS/FLI.6,7 The remaining cases contain other translocations that encode similar fusion proteins (EWS/ ERG, EWS/FEV, EWS/ETV…”
A new member of the ETS family fused to EWS in Ewing tumors
Peter, M., Couturier, J., Pacquement, H., Michon, J., Thomas, G., Magdelenat, H., & Delattre, O. (1997) · Oncogene · doi:10.1038/sj.onc.1200933 · Cited by 397
Nye, J. A., Petersen, J. M., Gunther, C. V., Jonsen, M. D., & Graves, B. J. (1992) · Genes & Development · doi:10.1101/gad.6.6.975 · Cited by 363
Research works printed but not linked: 1
- [20]May WA Lessnick SL Braun BS Klemsz M Lewis BC Lunsford LB The Ewing’s sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 Mol Cell Biol 1993 13 7393 8 8246959 PMC364810
Cited by
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
“In fact, four or more repeats are necessary for EWS-FLI1 transcriptional activation in reporter assays, and two EWS-FLI1 monomers bind to this four-motif array in biochemical assays (Figure 7) (133, 137, 187).”
Riggi, N., Knoechel, B., Gillespie, S. M., Rheinbay, E., Boulay, G., Suvà, M. L., Rossetti, N. E., Boonseng, W. E., Oksuz, O., Cook, E. B., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.004 · Cited by 445
“Binding of EWS-FLI1 to GGAA repeats has been reported previously, and sequences containing at least four GGAA repeats have been shown to favor the binding of EWSFLI1 as homodimers (Gangwal et al., 2010).”
BackgroundPromiscuous partnerships in Ewing's sarcoma
Sankar, S., & Lessnick, S. L. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.008 · Cited by 258
Self-citationChildren's Oncology Group's 2013 blueprint for research: Bone tumors
Gorlick, R., Janeway, K., Lessnick, S., Randall, R. L., Marina, N., & on behalf of the COG Bone Tumor Committee (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24429 · Cited by 226
Self-citationRecent advances in the molecular pathogenesis of Ewing's sarcoma
Toomey, E. C., Schiffman, J. D., & Lessnick, S. L. (2010) · Oncogene · doi:10.1038/onc.2010.205 · Cited by 191
“Follow-up studies have begun to unravel the mechanistic basis for EWS/FLI binding to microsatellite sequences and have suggested that similar mechanisms might also be used by other cancer-relevant ETS family members (Gangwal et al., 2010).”
BackgroundSelf-citationLoci-specific phase separation of FET fusion oncoproteins promotes gene transcription
Zuo, L., Zhang, G., Massett, M., Cheng, J., Guo, Z.-C., Wang, L., Gao, Y., Li, R., Huang, X., Li, P.-L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21690-7 · Cited by 123
“The genes coding Gal4 (1-147), MS2 coat protein, and Pol II CTDN26 (POLR2A) were obtained from Addgene (Plasmid nos.”
MethodPatel, M., Simon, J. M., Iglesia, M. D., Wu, S. B., McFadden, A. W., Lieb, J. D., & Davis, I. J. (2012) · Genome Research · doi:10.1101/gr.125666.111 · Cited by 114
“Although FLI1 can bind the tetranucleotide repeats both in vivo and in vitro, it fails to show activity at these repeats in reporter-based assays (Gangwal et al. 2008, 2010) suggesting that FLI1 requires the cooperation of other sequence-specific transcription factors to activate transcription.”
BackgroundMinas, T. Z., Surdez, D., Javaheri, T., Tanaka, M., Howarth, M., Kang, H., Han, J. J., Han, Z., Sax, B., Kream, B. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9388 · Cited by 116
“EWSFLI1 regulates target gene expression through GGAA microsatellite response elements [82-84].”
BackgroundKennedy, A. L., Vallurupalli, M., Chen, L., Crompton, B. D., Cowley, G. S., Vázquez, F., Weir, B. A., Tsherniak, A., Parasuraman, S., Kim, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4903 · Cited by 115
“Consistent with previous literature showing that GGAA microsatellites are a DNA binding motif of EWS/FLI1 [26], we found that GGAA microsatellites within EWS/ FLI1 peaks have more GGAA repeat counts than those residing in regions outside of the EWS/FLI1 peaks (Figure 1E).”
ResultHarlow, M. L., Maloney, N., Roland, J. T., Navarro, M. J. G., Easton, M. K., Kitchen-Goosen, S. M., Boguslawski, E. A., Madaj, Z., Johnson, B. K., Bowman, M. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0568 · Cited by 93
“Both wild-type FLI1 and EWS-FLI1 are capable of binding this microsatellite, but only EWS-FLI1 can activate transcription (40).”
Johnson, K. M., Mahler, N., Saund, R. S., Theisen, E. R., Taslim, C., Callender, N. W., Crow, J. C., Miller, K. R., & Lessnick, S. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701872114 · Cited by 90
“Binding and stoichiometry assays were performed as before (14).”
BackgroundMethodInfluentialSelf-citationTherapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
Theisen, E. R., Pishas, K. I., Saund, R. S., & Lessnick, S. L. (2016) · Oncotarget · doi:10.18632/oncotarget.7124 · Cited by 70
“While several ETS-family members can bind GGAA repetitive elements in vitro, only EWS-FLI is able to both bind and activate transcription at nearby genes [139].”
BackgroundSelf-citationJohnson, K. M., Taslim, C., Saund, R. S., & Lessnick, S. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186275 · Cited by 70
Self-citationKovar, H. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.947963 · Cited by 72
Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner
Harlow, M. L., Chassé, M. H., Boguslawski, E. A., Sorensen, K. M., Gedminas, J. M., Kitchen-Goosen, S. M., Rothbart, S. B., Taslim, C., Lessnick, S. L., Peck, A. S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3511 · Cited by 55
“CRISPR/Cas9 elimination of this microsatellite eliminates NR0B1 expression and while both FLI1 and EWSFLI1 can bind this region, only EWS-FLI1 can activate NR0B1 expression (12, 37, 38).”
BackgroundSelf-citationLu, D. Y., Ellegast, J. M., Ross, K. N., Malone, C. F., Lin, S., Mabe, N. W., Dharia, N. V., Meyer, A., Conway, A. S., Su, A. H., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-022-01059-8 · Cited by 57
Self-citationOncogenic ETS Factors in Prostate Cancer
Nicholas, T. R., Strittmatter, B. G., & Hollenhorst, P. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_18 · Cited by 58
EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma
Fadul, J., Bell, R. N., Hoffman, L. M., Beckerle, M. C., Engel, M. E., & Lessnick, S. L. (2015) · Genes & Cancer · doi:10.18632/genesandcancer.57 · Cited by 47
“We have previously shown that EWS/FLI is able to directly activate genes by binding GGAA microsatellite-rich promoters, while others demonstrated its binding with the transcriptional co-activator CBP/p300, or phosphorylation-dependent interaction with the C-terminal domain of RNA PolII itself [6-12].”
BackgroundSelf-citationBCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma
Wiles, E. T., Lui, B., Bell, R. N., & Lessnick, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059369 · Cited by 49
Self-citationMonument, M. J., Johnson, K. M., McIlvaine, E. J., Abegglen, L. M., Watkins, W. S., Jorde, L. B., Womer, R. B., Beeler, N., Monovich, L., Lawlor, E. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104378 · Cited by 46
“Initial studies characterizing the biochemical properties of these GGAA-microsatellite response elements demonstrated EWS/FLI DNA binding and subsequent transcriptional activation is highly dependent on the number of GGAA motifs within in the microsatellite: A minimum of 4 GGAA motifs is required for initial DNA bindi…”
BackgroundSelf-citationReview: Ewing Sarcoma Predisposition
Gargallo, P., Yáñez, Y., Juan, A. D., Segura, V., Balaguer, J., Torres, B., Oltra, S., Castel, V., & Cañete, A. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00765-3 · Cited by 47
Boone, M. A., Taslim, C., Crow, J. C., Selich‐Anderson, J., Byrum, A. K., Showpnil, I. A., Sunkel, B. D., Wang, M., Stanton, B. Z., Theisen, E. R., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01876-5 · Cited by 42
“To test both possible “ETS domains”, we created two new mutant forms of EWS/FLI: “EF DBD” 232 that fuses EWS directly to the 85-amino acid ETS domain and “EF DBD+” that fused EWS to a 233 102-amino acid ETS DNA-binding domain (containing 7- and 10-amino acid extensions on the 234 amino-terminal and carboxyl-terminal s…”
Self-citationCatalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy
Romo‐Morales, A., Aładowicz, E., Blagg, J., Gatz, S. A., & SHIPLEY, J. M. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27888 · Cited by 39
One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma
Flores, G., & Grohar, P. J. (2021) · Journal of bone oncology · doi:10.1016/j.jbo.2021.100404 · Cited by 42
“only EWS/FLI can transactivate and drive expression [21,148].”
BackgroundETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation
Gao, Y., He, X., Wu, X., Huang, Y., Toneyan, S., Ha, T., Ipsaro, J. J., Koo, P. K., Joshua‐Tor, L., Bailey, K. M., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-022-01060-1 · Cited by 46
Theisen, E. R., Selich‐Anderson, J., Miller, K. R., Tanner, J. M., Taslim, C., Pishas, K. I., Sharma, S., & Lessnick, S. L. (2020) · Epigenetics · doi:10.1080/15592294.2020.1805678 · Cited by 34
“De novo establishment of enhancers at GGAAμsats is unique to Ewing sarcoma, due to the altered binding specificity conferred to the FLI DBD in the fusion [12,45].”
BackgroundSelf-citationShowpnil, I. A., Miller, K. R., Taslim, C., Pishas, K. I., Lessnick, S. L., & Theisen, E. R. (2020) · Journal of Visualized Experiments · doi:10.3791/61564 · Cited by 30
Self-citationUchiumi, F., Miyazaki, S., & Tanuma, S.-I. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0674-x · Cited by 31
“The GGAAmicrosatellite is preferentially recognized and activated by EWS/FLI but not by Ets1 and Elk1, suggesting that transcription of genes containing GGAA-microsatellites is not usually regulated by Ets family proteins [47, 48].”
BackgroundGlutathione S-Transferases in Pediatric Cancer
Luo, W., Kinsey, M., Schiffman, J. D., & Lessnick, S. L. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00039 · Cited by 33
“Other work has shown that the ability of EWS/FLI to activate gene expression through GGAA-microsatellite response elements is proportional to the length of the microsatellite, suggesting that microsatellite polymorphisms might affect target gene expression (Gangwal et al., 2010).”
BackgroundSelf-citationTheisen, E. R., Miller, K. R., Showpnil, I. A., Taslim, C., Pishas, K. I., & Lessnick, S. L. (2019) · Genes & Cancer · doi:10.18632/genesandcancer.188 · Cited by 27
“6 kb promoter [11], 102 bp NR0B1 microsatellite [12], the 500 bp NR0B1 microsatellite [11], 10X GGAA, 20X GGAA, and 30X GGAA firefly luciferase reporter vectors are previously described [11, 33].”
BackgroundInfluentialSelf-citationLi, M., & Chen, C.-W. D. (2022) · Biomedicines · doi:10.3390/biomedicines10061325 · Cited by 25
“Since 2008, several research groups have demonstrated that EWSR1-FLI1 uses GGAAcontaining elements (microsatellites) as specific response elements to up-regulate genes dispersed throughout the human genome [19,20,34,35].”
BackgroundPrecision medicine in Ewing sarcoma: a translational point of view
Gargallo, P., Juan, A. D., Yáñez, Y., Dolz, S., Segura, V., Castel, V., & Cañete, A. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02298-7 · Cited by 22
Regulation of Metastasis in Ewing Sarcoma
Li, M., & Chen, C.-W. D. (2022) · Cancers · doi:10.3390/cancers14194902 · Cited by 23
Phase separation of the oncogenic fusion protein EWS::FLI1 is modulated by its DNA-binding domain
Selig, E. E., Sohn, E. J., Stoja, A. P., Moreno-Romero, A. K., Akula, S., Xu, X., Bishop, A. J. R., & Libich, D. S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221823122 · Cited by 26
Yamamoto-Shiraishi, Y.-I., Higuchi, H., Yamamoto, S., Hirano, M., & Kuroiwa, A. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.07.022 · Cited by 17
Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas
Lanzi, C., & Cassinelli, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114944 · Cited by 19
Microsatellites with Macro-Influence in Ewing Sarcoma
Monument, M. J., Johnson, K. M., Grossmann, A. H., Schiffman, J. D., Randall, R. L., & Lessnick, S. L. (2012) · Genes · doi:10.3390/genes3030444 · Cited by 21
“The affinity of EWS/FLI for the NR0B1 GGAA microsatellite and subsequent gene activation mediated by this interaction is well established [29,30,32,33,36,37].”
BackgroundMethodInfluentialSelf-citationSelig, E. E., Bhura, R., White, M. R., Akula, S., Hoffman, R. D., Tovar, C. N., Xu, X., Booth, R. E., & Libich, D. S. (2023) · Biopolymers · doi:10.1002/bip.23536 · Cited by 13
Children's Oncology Group's 2013 blueprint for research: Epidemiology
Spector, L. G., Ross, J. A., & Olshan, A. F. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24434 · Cited by 12
“In addition, recent data suggest that the length of microsatellites which are binding sites of the of EWS–FLI1 fusion protein influences downstream expression of Ewing sarcoma signaling pathways [63], suggesting that cases will have inherited a large number of consecutive GGAArepeats in specific EWS–FLI1 transcription…”
BackgroundSalient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
Monument, M. J., Bernthal, N. M., & Randall, R. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00024 · Cited by 16
“It is known that EWS/FLI and related EWS/ETS fusions up-regulate numerous target genes via a Frontiers in Oncology | Pediatric Oncology February 2013 | Volume 3 | Article 24 | 2 promoter-based GGAA microsatellite response element (Gangwal et al., 2008, 2010; Guillon et al., 2009).”
BackgroundThangaretnam, K. P., Gopisetty, G., Ramanathan, P., & Rajkumar, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-07482-4 · Cited by 11
Abdelbary, H., Brown, C. W., Werier, J. A., & Bell, J. C. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/171439 · Cited by 10
“Over 85%of EWS cells possess an aberrant chromosomal translocation involving chromosomes 11 and 22, which produces the oncogenic chimeric fusion protein EWS/FLI1 [2].”
BackgroundMethodKDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma
Figuerola-Bou, E., Ríos-Astorch, C., Blanco, E., Sánchez-Jiménez, M., Táboas, P., Fernández, G., Gómez‐González, S., Muñoz, O., Castellano‐Escuder, P., Pérez‐Jaume, S., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3452 · Cited by 7
“EWSR1::FLI1 exhibits a high affinity for binding DNA through GGAA motifs, a class of ETS-specific response elements, activating or repressing their targets based on the number of motif repeats (14, 15).”
Ewing sarcoma genomics and recent therapeutic advancements
Chavan, M., Dhakal, S., Singh, A., Rai, V., Arora, S., Mallipeddi, M. C., & Das, A. (2023) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2023.02.001 · Cited by 9
Suppression of USP7 negatively regulates the stability of ETS proto-oncogene 2 protein
Park, H., Min, Y., Hwang, S., & Baek, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114700 · Cited by 7
Uchiumi, F., Larsen, S. H., & Tanum, S.-I. (2013) · InTech eBooks · doi:10.5772/53905 · Cited by 6
“The EWS/FLI binds to these promoter regions acti‐ vating their transcription [44].”
BackgroundStructure and cooperative formation of a FLI1 filament on contiguous GGAA DNA sites
Hou, C., & Tsodikov, O. V. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf205 · Cited by 6
“Both structures contain one multi-protein–DNA complex per asymmetric unit, where the DNA molecules are not bent, consistent with previous EMSA studies [ 38 ].”
Biological Functions of the Duplicated GGAA-motifs in Various Human Promoter Regions
Uchiumi, F., Miyazaki, S., & Tanuma, S.-I. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.1787 · Cited by 4
Epigenetic Analysis in Ewing Sarcoma
Simon, J. M., & Gomez, N. C. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_22 · Cited by 3
Selig, E. E., Moreno-Romero, A. K., Akula, S., Xu, X., & Libich, D. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.04.494830 · Cited by 5
Kaufman, R., Flores, G., Boguslawski, E. A., Kinn-Gurzo, S. S., Chassé, M. H., Beddows, I., Adams, M., Stout, M. C., Gaetano, L. M., Lopez, R. D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69488-9 · Cited by 2
Tirode, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00022-4 · Cited by 1
Single-Molecule Imaging of EWS-FLI1 Condensates Assembling on DNA
Zuo, L., Ding, J., & Qi, Z. (2021) · Journal of Visualized Experiments · doi:10.3791/62974 · Cited by 1
“EWSFLI1 is a fusion protein combining the N-terminal of EWSR1 (1-265) and the C-terminal of FLI1 (220-453).”
BackgroundFusion and Wildtype Proteins of EWSR1 Interact in a Protein Granule
Ahmed, N. S. (2020) · UA Campus Repository (The University of Arizona)
Integrative Molekularpathologie von Krebserkrankungen
Grünewald, T. G. P. (2020) · Der Pathologe · doi:10.1007/s00292-020-00870-0
Molecular aspects of Ewing's sarcomas
Tirode, F., & Grünewald, T. G. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00022-0
de Stefani, R. R., de Toni, E. C., de Farias, C. B., Brunetto, A. T., Brunetto, A. L., Roesler, R., Alho, C. S., & Friedrich, D. C. (2022) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2022v68n2.2350
Lessnick, S. L. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726363754.793558277
Self-citation(2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54806-9.50087-2
Sarcoma de Ewing de presentación extraesquelética. Reporte de caso
López-Hernández, W., Sánchez‐Ríos, C. P., Vázquez-Manríquez, M. E., Jiménez-López, J., Bolaños-Morales, F. V., Alatorre-Alexander, J., Martínez-Barrera, L. M., Castillo-González, P., Pedraza-Reyes, S. M., & Rodríguez‐Cid, J. R. (2024) · Gaceta Mexicana de Oncología · doi:10.24875/j.gamo.23000066
“Lo anterior conduce a la formación del gen de fusión EWSR1-FLI1 7 , al involucrar factores de transcripción, las proteínas resultantes de este pro-ceso aberrante son capaces de desregular cientos de genes implicados en procesos importantes tales como la regulación del ciclo celular o la migración…”
Condensates in fusion oncoprotein-driven leukemia: new biology and therapeutic opportunities
Michmerhuizen, N. L., Kriwacki, R. W., & Mullighan, C. G. (2026) · Trends in cancer · doi:10.1016/j.trecan.2026.04.009
Oncogenic fusions induce an extensive cancer-restricted cryptic proteome in Ewing sarcomaPreprint
Broeils, L. A., Pilet, J., Koshkina, M. K., Li, J., Grossetête, S., Westerink, E. G. A., Jay, O., Smit, L., Luo, T., Narmanli, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.16.751792
Molnar, C., Reina, J., Mora, J., & González, C. (2026) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkag265
Ancient and animal-specific regulatory modes of EWS::FLI1 revealed by a minimal yeast model
Velázquez, D., Molnar, C., Reina, J., Mora, J., & González, C. (2026) · PNAS Nexus · doi:10.1093/pnasnexus/pgag329
“…are associated with these elements, and that GGAA μ Sats-driven ectopic enhancers can influence both proximal and distal genes (10, 13), it is widely accepted that activation of GGAA μ Sats represents the primary mechanism by which EWS::FLI1 directly dysregulates gene expression (8 – 10, 12, 17).”
The roles of LLPS in transcription and chromatin organization in oncofusion-driven cancers
Gherghelas, A.-M., & Toseland, C. P. (2026) · Critical Insights in Biophysics · doi:10.1080/29932203.2026.2733916
Epigenetic Analysis in Ewing Sarcoma
Urzì, O., Stelzer, T., Sims, J., & Tomazou, E. M. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5587-0_28
Metadata
- Authors
- Gangwal, K., Close, D., Enriquez, C. A., Hill, C. P., & Lessnick, S. L.
- Affiliations
- University of Utah (US)
- Corresponding author
- Lessnick, S. L.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2010-02-01
- Volume
- 1
- Issue
- 2
- Pages
- 177-187
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- PMC
- PMC2935179
- OpenAlex
- W2092360628
- Cited by
- 67
- References
- 45
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 7 · 2019: 6 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 6 · 2013: 3 · 2012: 3
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Cancer (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Huntsman Cancer Foundation
- National Institutes of Health
- National Cancer Institute (P30CA042014)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- Ewing sarcoma, ETS transcription factors, DNA binding, homodimerization, ETS domain, transcriptional activation, NR0B1, promoter regulation, protein-DNA binding affinity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.